Repurposing Disulfiram as an Anti-Cancer Agent: Updated Review on Literature and Patents.

CONCLUSION: For years the FDA-approved, well-tolerated, inexpensive, orally-administered drug Disulfiram was used in the treatment of chronic alcoholism, but it has recently demonstrated anti-cancer effects in a range of solid and hematological malignancies. Its combination with clinically relevant copper concentrations might overcome the resistance of many anti-cancer drugs in vitro, in vivo, and in patients. PMID: 31084595 [PubMed - as supplied by publisher]
Source: Recent Patents on Anti-Cancer Drug Discovery - Category: Cancer & Oncology Tags: Recent Pat Anticancer Drug Discov Source Type: research

Related Links:

Pfizer has agreed to buy Array Biopharma in a $10.64 billion cash deal.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
Source: BMJ News - Category: General Medicine Source Type: research
(CNN) — Your social media could reveal a lot more about you than you think. Say, for example, whether you have a medical condition. In a new study, researchers were able to predict 21 types of medical conditions — ranging from pregnancy to skin disorders — by analyzing people’s Facebook profiles. Facebook status updates were “particularly effective at predicting diabetes and mental health conditions including anxiety, depression and psychoses,” the study found. The study will be published June 19 in PLOS One, a peer-reviewed open access scientific journal published since 2006 “Peop...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News Offbeat CNN Facebook Source Type: news
CCR Grand Rounds Kimberly Stegmaier, M.D., Professor of Pediatrics at Harvard Medical School and the Ted Williams Chair at Dana-Farber Cancer Institute, has advanced the application of genomics to drug and protein target discovery for pediatric cancers. She is the Vice Chair for Pediatric Oncology Research, co-director of the Pediatric Hematologic Malignancy Program and an attending physician providing clinical care in Pediatric Oncology at the Dana-Farber Cancer Institute and Boston Children ’ s Hospital. Dr. Stegmaier is also an Institute Member of the Broad Institute of Harvard and MIT. She has served as a Council...
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
ConclusionExperimental validation of network analysis revealed anti-diabetic effects of the plant product SGD, manifested most notably by improved serum profiles and diminished insulin resistance. These experimental results may have clinical implications.Graphical abstract
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
Abstract We hypothesize that, ancestrally, sex-specific immune modulation evolved to facilitate survival of the pregnant person in the presence of an invasive placenta and an immunologically challenging pregnancy - an idea we term the 'pregnancy compensation hypothesis' (PCH). Further, we propose that sex differences in immune function are mediated, at least in part, by the evolution of gene content and dosage on the sex chromosomes, and are regulated by reproductive hormones. Finally, we propose that changes in reproductive ecology in industrialized environments exacerbate these evolved sex differences, resulting...
Source: Trends in Genetics : TIG - Category: Genetics & Stem Cells Authors: Tags: Trends Genet Source Type: research
During this first awards program the Office of Equity, Diversity and Inclusion (EDI) will honor these NIH employees and fellows who are community members and allies nominated for their exemplary work helping to create safer spaces for SGM at the NIH. These awardees lead by example and encourage others to demonstrate unconditional compassion, leadership, and understanding towards members of the SGM community: Dr. Vivian Ota Wang, National Cancer Institute; Dr. Christopher Wheldon, National Cancer Institute; Adam Cornish, National Institute on Aging; Dr. Karen Parker, Sexual&Gender Minority Research Office, Tricia Coffey...
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
Findings seen among pre - /perimenopausal survivors of stage 0 to III breast cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nursing, Oncology, Orthopedics, Rheumatology, Journal, Source Type: news
For several decades, certain cancer centers have been allowed by the U.S. government to charge more for the care they give. A new study finds the care given at these centers isn't very different from that received at other top-notch facilities.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
A couple of years ago a team of U.S. and U.K. scientists came up with a way of making molecular motors that can drill through cancer cells, destroying them in the process. The researchers, from Rice University, Durham University, and North Carolina S...
Source: Medgadget - Category: Medical Devices Authors: Tags: Medicine Nanomedicine Oncology Source Type: blogs
More News: Alcoholism | Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Cancer Therapy | Copper | Gastroschisis Repair | Hematology | Multidrug Resistance | Neurology